← All organizations

Fennec Pharma

For profit

Also known as: Fennec Pharma | FENNEC PHARMS INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

First marketed drug

Last known activity

Sep 20, 2022

Timeline

1990s

Jun 1, 1996
Fennec Pharma— Founded

2020s

Sep 20, 2022
sodium thiosulfate— Marketing Organization
Sep 20, 2022
sodium thiosulfate— NDA Secondary Org

Drugs by trial phase (11 distinct, 11 trials)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

sodium thiosulfate

Indications

Studied for

Marketed drugs (1)

sodium thiosulfate

Recent trials (11)

NCT04132882CollaboratorN/A—
NCT01825603CollaboratorPhase 1Apr 1, 2013
NCT01231802Lead sponsorPhase 2Apr 1, 2011
NCT00421811Lead sponsorPhase 1/Phase 2Apr 1, 2007
NCT00390676Lead sponsorPhase 1Nov 1, 2006
NCT00319683Lead sponsorPhase 1/Phase 2Apr 27, 2006
NCT00264472Lead sponsorPhase 1Jan 1, 2006
NCT00264446Lead sponsorPhase 1Dec 12, 2005
NCT00264433Lead sponsorPhase 2Dec 12, 2005
NCT00225550Lead sponsorPhase 1/Phase 2Sep 22, 2005
NCT00265057Lead sponsorPhase 1/Phase 2Jun 1, 2005

Details

Founded: Raleigh, NC, US Jun 1, 1996
Last known activity: Sep 20, 2022

Notes

formerly Adherex Technologies, Inc.